Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to B-cell Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
- Status
- RECRUITING
- Phase
- N/A
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
- Status
- RECRUITING
- Phase
- PHASE1
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
- Status
- RECRUITING
- Phase
- PHASE2
Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- NA
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
- Status
- RECRUITING
- Phase
- PHASE1
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
- Status
- RECRUITING
- Phase
- PHASE1
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A